BPC-157

Research OnlyModerate Evidence
Written by dr-sarah-chen|Reviewed by Healthier Rx Editorial Board|Updated 2026-03-25|4 min read
Quick Facts
TypeHealing & Recovery
FDA StatusResearch Only
Evidence LevelModerate Evidence
Typical Dose250-500mcg
FrequencyTwice daily
Cycle Length4-8 weeks
Key GoalsInjury Recovery, Gut Health, Joint Health

How It Works

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. It consists of 15 amino acids and has been extensively studied in animal models for its remarkable healing properties.

The peptide works through multiple mechanisms: it upregulates growth hormone receptor expression in injured tissues, promotes angiogenesis (new blood vessel formation), and modulates the nitric oxide system. These combined effects accelerate the healing of tendons, ligaments, muscles, bones, and gastrointestinal tissue.

Benefits

  • Accelerated healing of tendons, ligaments, and muscles in animal studies
  • Gastroprotective effects — protects and heals gut lining
  • Neuroprotective properties demonstrated in rodent models
  • Anti-inflammatory effects through modulation of the nitric oxide pathway
  • May improve blood vessel formation at injury sites

Side Effects

  • Generally well-tolerated in animal studies with no reported organ toxicity
  • Injection site reactions (redness, mild pain) — common with subcutaneous injection
  • Mild nausea — occasionally reported, especially with oral dosing
  • Dizziness — rarely reported
  • No significant adverse effects documented in published literature

Dosing Protocol

ParameterDetails
Standard Dose250-500mcg per injection
FrequencyTwice daily (morning and evening)
AdministrationSubcutaneous injection near injury site, or oral for gut applications
Cycle Length4-8 weeks
TitrationStart at 250mcg and increase to 500mcg if tolerated

What You Will Need

  • BPC-157 lyophilized vial (typically 5mg)
  • Bacteriostatic water (30mL)
  • Insulin syringes (1mL, 29-31ga)
  • Alcohol swabs
  • Sharps container

Frequently Asked Questions

References

  1. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tractCurrent Pharmaceutical Design (2011). PMID: 21861804

    Comprehensive review of BPC-157's gastroprotective and healing properties across multiple organ systems.

  2. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblastsGrowth Hormone & IGF Research (2014). PMID: 24893812

    Demonstrates BPC-157's mechanism in tendon healing through GH receptor upregulation.

Compare BPC-157

Protocols Featuring BPC-157

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new treatment or protocol. Read our full medical disclaimer.